# Neuronetics, Inc. Common Stock (STIM)

> Neuronetics, Inc. Common Stock (STIM) trades at $2.01 (-7.80%) as of 4:29:00 PM EST on Nov 10, 2026, -5.63% over the past month. Market cap is $169.45M, with 9.4 days to cover in short interest.

Canonical: https://massive.com/quote/stim
Data as of: 2026-11-10T21:29:00.407Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$2.01** -0.17 (-7.80%)
At close · 15-minute delayed
Nasdaq · usd

After hours: **$1.82** -0.19 (-9.45%)
As of 4:29:00 PM EST on Nov 10, 2026 · After hours

## Stock performance

How Neuronetics, Inc. Common Stock (STIM) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -7.80% |
| 1W | -11.06% |
| 1M | -5.63% |
| YTD | +45.65% |
| 1Y | -8.64% |
| 52-wk range | $0.80 – $3.44 |

From daily closes through Nov 10, 2026.

## Key statistics

Today's trading snapshot for STIM: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $1.98 – $2.22 |
| Open | $2.17 |
| Prev close | $2.18 |
| Volume | 1.21M |
| Market cap | $169.45M |
| Shares out | 77.73M |

## Valuation and profitability ratios

Valuation and profitability ratios for Neuronetics, Inc. Common Stock: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | — |
| P/S | 1.05 |
| P/B | 8.93 |
| P/FCF | — |
| ROE | -123.4% |
| ROA | -17.5% |
| Debt/Equity | 3.30 |
| Div yield | 0.00% |

As of Nov 6, 2026

## Insider trading

[Neuronetics, Inc. Common Stock (STIM) insider trading](https://massive.com/quote/stim/insider-trading.md): open-market Form 4 buys and sells by Neuronetics, Inc. Common Stock insiders over the last 12 months.

## 8-K filings

Material corporate events Neuronetics, Inc. Common Stock has disclosed to the SEC on Form 8-K.

- Nov 4, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “Neuronetics, Inc. (the "Company") issued a press release on November 4, 2026, announcing its financial results for the three and nine months ended September 30, 2026.”
- Aug 17, 2026 · Cfo appointment
  “On August 12, 2026, the Board appointed Mr. Naor to serve as the Company's principal financial and accounting officer. Mr. Naor's title is now Executive Vice President, Chief Financial Officer, Corporate Secretary, and Treasurer. Mr. Naor's biographical information can be found in the Company's Current Report on Form 8-K filed on July 20, 2026.”
- Jul 20, 2026 · Executive compensation change
  “On the Separation Date, Mr. Macan will be entitled to his retention bonus in the gross amount of $231,750.00 and the retention award granted to him by the Board of Directors of the Company (the "Board") on December 30, 2025 in the amount of 164,361 Restricted Stock Units, which shall vest on the Separation Date. Mr. Macan will also be entitled to a Separation Payment in the amount of $475,087.50, minus taxes and withholdings payable on regularly scheduled payroll dates for a consecutive period of 12 months.”
- Jun 23, 2026 · Executive compensation change
  “In connection with Mr. Anderson's promotion, the Board has approved changes to Mr. Anderson's employment terms. Effective as of the Anderson Promotion Date, Mr. Anderson's annual base salary will be increased to $425,000, and Mr. Anderson's target discretionary annual cash bonus will be increased to 45% of his then-current base salary.”
- May 29, 2026 · Annual meeting results
  “Neuronetics, Inc. (the "Company") held its Annual Meeting of Stockholders on May 28, 2026 (the "Annual Meeting"). A total of 55,950,118 shares of common stock, representing approximately 80.41% of the shares outstanding and eligible to vote and constituting a quorum, were represented in person or by valid proxies at the Annual Meeting. The final results for each of the matters submitted to a vote of stockholders at the Annual Meeting are as follows:”

## STIM short interest

How heavily STIM is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 9.4 |
| Short interest | 7.21M |
| Avg volume | 764.55K |

As of Oct 15, 2026 · reported to FINRA twice monthly.

## STIM news

The latest news and headlines about Neuronetics, Inc. Common Stock (STIM).

- [Neuronetics (STIM) Reports Q3 Loss, Tops Revenue Estimates](https://www.zacks.com/stock/news/3023090/neuronetics-stim-reports-q3-loss-tops-revenue-estimates?cid=CS-ZC-FT-fundamental_analysis|yseop_template_4-3023090) · Zacks Investment Research · Nov 4, 2026 · positive sentiment
- [Beta Bionics, Inc. (BBNX) Reports Q3 Loss, Beats Revenue Estimates](https://www.zacks.com/stock/news/3016441/beta-bionics-inc-bbnx-reports-q3-loss-beats-revenue-estimates?cid=CS-ZC-FT-fundamental_analysis|yseop_template_4-3016441) · Zacks Investment Research · Oct 27, 2026 · neutral sentiment
- [Integra LifeSciences (IART) Surpasses Q3 Earnings Estimates](https://www.zacks.com/stock/news/3011571/integra-lifesciences-iart-surpasses-q3-earnings-estimates?cid=CS-ZC-FT-fundamental_analysis|yseop_template_4-3011571) · Zacks Investment Research · Oct 21, 2026 · neutral sentiment
- [Deal Dispatch: Unilever Buys Grüns, Pershing Square Eyes Universal Music Group, Saks Global Reorganization Plan](https://www.benzinga.com/m-a/26/04/51762292/deal-dispatch-unilever-pershing-square-universal-music-saks-global?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel) · Benzinga · Apr 10, 2026 · positive sentiment
- [Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://www.globenewswire.com/news-release/2025/10/31/3178647/0/en/Neuronetics-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html) · GlobeNewswire Inc. · Oct 31, 2025 · positive sentiment

## About Neuronetics, Inc. Common Stock

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 658 |
| Listed | Jun 28, 2018 |

[Company website](https://www.neurostar.com)

## FAQ

### What is the Neuronetics, Inc. Common Stock (STIM) stock price today?

Neuronetics, Inc. Common Stock (STIM) is trading at $2.01 (-7.80% on the day) as of 4:29:00 PM EST on Nov 10, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Neuronetics, Inc. Common Stock?

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.

### What is the short interest in STIM?

As of Oct 15, 2026, STIM has 7.21M shares short and 9.4 days to cover.

### What exchange is STIM listed on?

Neuronetics, Inc. Common Stock (STIM) trades on Nasdaq in USD, in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.

## Live data

Prices here are 15-minute delayed. For real-time STIM quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=STIM`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Neuronetics, Inc. Common Stock (STIM) insider trading](https://massive.com/quote/stim/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
